The Role of Mesenchymal Stromal Cells and Their Products in the Treatment of Injured Spinal Cords

Spinal cord injury (SCI) is a destructive condition that results in lasting neurological damage resulting in disruption of the connection between the central nervous system and the rest of the body. Currently, there are several approaches in the treatment of a damaged spinal cord; however, none of the methods allow the patient to return to the original full-featured state of life before the injury. Cell transplantation therapies show great potential in the treatment of damaged spinal cords. The most examined type of cells used in SCI research are mesenchymal stromal cells (MSCs). These cells are at the center of interest of scientists because of their unique properties. MSCs regenerate the injured tissue in two ways: (i) they are able to differentiate into some types of cells and so can replace the cells of injured tissue and (ii) they regenerate tissue through their powerful known paracrine effect. This review presents information about SCI and the treatments usually used, aiming at cell therapy using MSCs and their products, among which active biomolecules and extracellular vesicles predominate.

[1]  N. Baldini,et al.  Intra-individual variability in the neuroprotective and promyelinating properties of conditioned culture medium obtained from human adipose mesenchymal stromal cells , 2023, Stem Cell Research & Therapy.

[2]  Cheng Wang,et al.  A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication , 2023, Cell Communication and Signaling.

[3]  A. Awidi,et al.  Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury , 2023, The American journal of case reports.

[4]  K. So,et al.  Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Wenwei Jiang,et al.  Exosomes combined with biomaterials in the treatment of spinal cord injury , 2023, Frontiers in Bioengineering and Biotechnology.

[6]  Y. Liu,et al.  Three-dimensional-cultured MSC-derived exosome with hydrogel for cerebral ischemia repair. , 2023, Biomaterials advances.

[7]  M. Shekh,et al.  Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives , 2023, International journal of biological sciences.

[8]  L. Slovinská,et al.  Characterisation of mesenchymal stem cells conditioned media obtained at different conditioning times: their effect on glial cells in in vitro scratch model , 2023, Growth factors.

[9]  Xiaoli Tian,et al.  Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury , 2022, Neural regeneration research.

[10]  Kexin Chen,et al.  Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury , 2022, BioMed research international.

[11]  G. Sukhikh,et al.  Human Multipotent Mesenchymal Stromal Cell–Derived Extracellular Vesicles Enhance Neuroregeneration in a Rat Model of Sciatic Nerve Crush Injury , 2022, International journal of molecular sciences.

[12]  Hengxing Zhou,et al.  Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury. , 2022, Bioactive materials.

[13]  E. Mazzon,et al.  Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury? , 2022, International journal of molecular sciences.

[14]  L. Dargahi,et al.  Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke , 2022, CNS neuroscience & therapeutics.

[15]  J. Kocsis,et al.  Enhanced Network in Corticospinal Tracts after Infused Mesenchymal Stem Cells in Spinal Cord Injury , 2022, Journal of neurotrauma.

[16]  M. Misra,et al.  Safety and feasibility of intramedullary injected bone marrow-derived mesenchymal stem cells in acute complete spinal cord injury: phase 1 trial. , 2022, Journal of neurosurgery. Spine.

[17]  E. Candi,et al.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.

[18]  M. Seo,et al.  Human Epidural AD–MSC Exosomes Improve Function Recovery after Spinal Cord Injury in Rats , 2022, Biomedicines.

[19]  Y. Higami,et al.  Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats , 2022, PloS one.

[20]  L. Slovinská,et al.  Mesenchymal Stem Cells in the Treatment of Human Spinal Cord Injury: The Effect on Individual Values of pNF-H, GFAP, S100 Proteins and Selected Growth Factors, Cytokines and Chemokines , 2022, Current issues in molecular biology.

[21]  L. Rong,et al.  Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury , 2022, Neural regeneration research.

[22]  M. V. Kiselevskii,et al.  Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory? , 2021, Bulletin of Experimental Biology and Medicine.

[23]  Chenghai Li,et al.  Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice , 2021, Cell & bioscience.

[24]  A. Nógrádi,et al.  Stem Cell Secretome for Spinal Cord Repair: Is It More than Just a Random Baseline Set of Factors? , 2021, Cells.

[25]  Hyo Jeong Kim,et al.  Brain-Derived Neurotrophic Factor Secreting Human Mesenchymal Stem Cells Improve Outcomes in Rett Syndrome Mouse Models , 2021, Frontiers in Neuroscience.

[26]  D. Salzig,et al.  Scaled preparation of extracellular vesicles from conditioned media. , 2021, Advanced drug delivery reviews.

[27]  Z. Suo,et al.  Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine , 2021, Cells.

[28]  Qiuli Liu,et al.  Mesenchymal Stem Cell-Macrophage Crosstalk and Maintenance of Inflammatory Microenvironment Homeostasis , 2021, Frontiers in Cell and Developmental Biology.

[29]  F. Djouad,et al.  The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming , 2021, Frontiers in Immunology.

[30]  M. Farhoudi,et al.  Design of graphenic nanocomposites containing chitosan and polyethylene glycol for spinal cord injury improvement , 2021, RSC advances.

[31]  J. Silver,et al.  New insights into glial scar formation after spinal cord injury , 2021, Cell and Tissue Research.

[32]  L. Lossi,et al.  Mesenchymal stem cell conditioned medium increases glial reactivity and decreases neuronal survival in spinal cord slice cultures , 2021, Biochemistry and biophysics reports.

[33]  G. Terstappen,et al.  Strategies for delivering therapeutics across the blood–brain barrier , 2021, Nature Reviews Drug Discovery.

[34]  R. Rennert,et al.  Review of operative considerations in spinal cord stem cell therapy , 2021, World journal of stem cells.

[35]  X. Sui,et al.  Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies , 2021, Stem cells translational medicine.

[36]  X. Kang,et al.  Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury , 2021, Stem Cell Research & Therapy.

[37]  B. Liu,et al.  Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study. , 2020, Cytotherapy.

[38]  J. Benito-Penalva,et al.  Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. , 2020, Cytotherapy.

[39]  Q. H. Looi,et al.  Treatment of spinal cord injury with mesenchymal stem cells , 2020, Cell & bioscience.

[40]  J. Innes,et al.  An In Vitro Comparison of the Neurotrophic and Angiogenic Activity of Human and Canine Adipose-Derived Mesenchymal Stem Cells (MSCs): Translating MSC-Based Therapies for Spinal Cord Injury , 2020, Biomolecules.

[41]  J. Phillips,et al.  Cell Therapies for Spinal Cord Injury: Trends and Challenges of Current Clinical Trials. , 2020, Neurosurgery.

[42]  W. Banks,et al.  Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.

[43]  S. Mousavi,et al.  Umbilical cord-derived mesenchymal stem cells in neurodegenerative disorders: from literature to clinical practice. , 2020, Regenerative medicine.

[44]  Y. Niu,et al.  The role of hepatocyte growth factor in mesenchymal stem cell-induced recovery in spinal cord injured rats , 2020, Stem Cell Research & Therapy.

[45]  Jianqing Gao,et al.  Transplantation of Human Mesenchymal Stem Cell-Derived Exosomes Immobilized in An Adhesive Hydrogel for Effective Treatment of Spinal Cord Injury. , 2020, Nano letters.

[46]  Ling-ling Wu,et al.  Repairing and Analgesic Effects of Umbilical Cord Mesenchymal Stem Cell Transplantation in Mice with Spinal Cord Injury , 2020, BioMed research international.

[47]  Shusen Cui,et al.  Dissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury , 2020, Frontiers in Cellular Neuroscience.

[48]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[49]  I. Martin,et al.  Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. , 2019, Cytotherapy.

[50]  Y. Kusnadi,et al.  Motoric Recovery After Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Chronic Spinal Cord Injury: A Case Report. , 2019, The American journal of case reports.

[51]  A. Hoffmann,et al.  BDNF‐overexpressing human mesenchymal stem cells mediate increased neuronal protection in vitro , 2019, Journal of neuroscience research.

[52]  M. Gimona,et al.  Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. , 2019, Cytotherapy.

[53]  A. Vercelli,et al.  Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy , 2019, International journal of molecular sciences.

[54]  Zhifeng Xiao,et al.  Different functional bio-scaffolds share similar neurological mechanism to promote locomotor recovery of canines with complete spinal cord injury. , 2019, Biomaterials.

[55]  C. Tonda-Turo,et al.  Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment , 2019, Scientific Reports.

[56]  Jianghua Chen,et al.  Genetic communication by extracellular vesicles is an important mechanism underlying stem cell-based therapy-mediated protection against acute kidney injury , 2019, Stem Cell Research & Therapy.

[57]  M. Cifuentes,et al.  Comparative analysis and characterization of soluble factors and exosomes from cultured adipose tissue and bone marrow mesenchymal stem cells in canine species. , 2019, Veterinary immunology and immunopathology.

[58]  R. Berebichez-Fridman,et al.  Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. , 2018, Sultan Qaboos University medical journal.

[59]  Changsheng Wang,et al.  Neural differentiation of bone marrow mesenchymal stem cells with human brain‐derived neurotrophic factor gene‐modified in functionalized self‐assembling peptide hydrogel in vitro , 2018, Journal of cellular biochemistry.

[60]  J. Innes,et al.  Exposing mesenchymal stem cells to chondroitin sulphated proteoglycans reduces their angiogenic and neuro-adhesive paracrine activity. , 2018, Biochimie.

[61]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[62]  M. Fehlings,et al.  Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury , 2018, Stem cell reports.

[63]  H. Noristani,et al.  CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury , 2018, Front. Cell. Neurosci..

[64]  Yue Zhou,et al.  Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury , 2018, Journal of neuroinflammation.

[65]  J. Carballido,et al.  Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. , 2018, Cytotherapy.

[66]  Sai Zhang,et al.  Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells , 2018, Cell transplantation.

[67]  B. S. Ramalho,et al.  Injection of bone marrow mesenchymal stem cells by intravenous or intraperitoneal routes is a viable alternative to spinal cord injury treatment in mice , 2018, Neural regeneration research.

[68]  E. Ling,et al.  Neurotrophin‐3 released from implant of tissue‐engineered fibroin scaffolds inhibits inflammation, enhances nerve fiber regeneration, and improves motor function in canine spinal cord injury , 2018, Journal of biomedical materials research. Part A.

[69]  B. Yue,et al.  Promotion of neurological recovery in rat spinal cord injury by mesenchymal stem cells loaded on nerve‐guided collagen scaffold through increasing alternatively activated macrophage polarization , 2018, Journal of tissue engineering and regenerative medicine.

[70]  Yulin Li,et al.  Rat vibrissa dermal papilla cells promote healing of spinal cord injury following transplantation , 2018, Experimental and therapeutic medicine.

[71]  A. Spittler,et al.  Isolation, cultivation, and characterization of human mesenchymal stem cells , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[72]  V. Nogueira Silbiger,et al.  Identification of new genes associated to senescent and tumorigenic phenotypes in mesenchymal stem cells , 2017, Scientific Reports.

[73]  Wutian Wu,et al.  Effect of VEGF on Inflammatory Regulation, Neural Survival, and Functional Improvement in Rats following a Complete Spinal Cord Transection , 2017, Front. Cell. Neurosci..

[74]  Wu Jun Zhu He Yu Tian-fei Chen Gang Progress of Stem Cell Therapy in Spinal Cord Injury , 2017 .

[75]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[76]  Wei Xu,et al.  Mesenchymal Stem Cells Modulate Light-induced Activation of Retinal Microglia Through CX3CL1/CX3CR1 Signaling , 2016, Ocular immunology and inflammation.

[77]  Pedro Quelhas,et al.  Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells , 2016, Journal of The Royal Society Interface.

[78]  J. H. Park,et al.  Comparative Efficacies of Long-Term Serial Transplantation of Syngeneic, Allogeneic, Xenogeneic, or CTLA4Ig-Overproducing Xenogeneic Adipose Tissue-Derived Mesenchymal Stem Cells on Murine Systemic Lupus Erythematosus , 2016, Cell transplantation.

[79]  Q. Han,et al.  Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a , 2016, Journal of Cell Science.

[80]  M. Yousefifard,et al.  Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model , 2016, Stem Cell Research & Therapy.

[81]  D. Hu,et al.  The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy , 2015, Stem Cell Research & Therapy.

[82]  M. Rodríguez-Vázquez,et al.  Chitosan and Its Potential Use as a Scaffold for Tissue Engineering in Regenerative Medicine , 2015, BioMed research international.

[83]  I. Fournier,et al.  Delivery of Alginate Scaffold Releasing Two Trophic Factors for Spinal Cord Injury Repair , 2015, Scientific Reports.

[84]  Dingding Li,et al.  VEGF inhibits the inflammation in spinal cord injury through activation of autophagy. , 2015, Biochemical and biophysical research communications.

[85]  L. Ding,et al.  Haploidentical hematopoietic stem cell transplant with umbilical cord-derived multipotent mesenchymal cell infusion for the treatment of high-risk acute leukemia in children , 2015, Leukemia & lymphoma.

[86]  A. Salgado,et al.  Secretome of Mesenchymal Progenitors from the Umbilical Cord Acts as Modulator of Neural/Glial Proliferation and Differentiation , 2014, Stem Cell Reviews and Reports.

[87]  T. Yoshimine,et al.  Intranasal delivery of bone marrow stromal cells to spinal cord lesions. , 2015, Journal of neurosurgery. Spine.

[88]  Yu-ke Tian,et al.  Anti-inflammatory Mechanism of Bone Marrow Mesenchymal Stem Cell Transplantation in Rat Model of Spinal Cord Injury , 2015, Cell Biochemistry and Biophysics.

[89]  H. Okano,et al.  Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition , 2015, Stem cell reports.

[90]  Yang-qiu Li,et al.  Immunogenicity of allogeneic mesenchymal stem cells transplanted via different routes in diabetic rats , 2014, Cellular and Molecular Immunology.

[91]  Š. Kubínová,et al.  Human Mesenchymal Stem Cells Modulate Inflammatory Cytokines after Spinal Cord Injury in Rat , 2014, International journal of molecular sciences.

[92]  H. Gabr,et al.  Autologous Bone Marrow-Derived Cell Therapy Combined with Physical Therapy Induces Functional Improvement in Chronic Spinal Cord Injury Patients , 2014, Cell transplantation.

[93]  J. Rubin,et al.  Adipose stem cells: biology and clinical applications for tissue repair and regeneration. , 2014, Translational research : the journal of laboratory and clinical medicine.

[94]  T. Yi,et al.  Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in b lymphocytes , 2014, Cell Death and Disease.

[95]  J. Karp,et al.  Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.

[96]  M. Griffin,et al.  Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy? , 2014, Current opinion in organ transplantation.

[97]  D. Yoo,et al.  Neuroprotective Effects of Adipose-Derived Stem Cells Are Maintained for 3 Weeks against Ischemic Damage in the Rabbit Spinal Cord , 2014, BioMed research international.

[98]  D. Howells,et al.  Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies , 2013, PLoS biology.

[99]  Y. Joe,et al.  A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells , 2013, Biomolecules & therapeutics.

[100]  J. Chang,et al.  Molecular Sciences Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy , 2022 .

[101]  K. Tarte,et al.  Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints. , 2013, Cytotherapy.

[102]  K. Wood,et al.  Mesenchymal stromal cells in transplantation rejection and tolerance. , 2013, Cold Spring Harbor perspectives in medicine.

[103]  J. Leor,et al.  Human Macrophage Regulation Via Interaction With Cardiac Adipose Tissue-Derived Mesenchymal Stromal Cells , 2013, Journal of cardiovascular pharmacology and therapeutics.

[104]  Yi Li,et al.  Exosome‐Mediated Transfer of miR‐133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth , 2012, Stem cells.

[105]  Arnold I Caplan,et al.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models , 2012, Nature Neuroscience.

[106]  H. Baba,et al.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. , 2012, Journal of neurotrauma.

[107]  A. Gasbarrini,et al.  Neurotrophic Features of Human Adipose Tissue-Derived Stromal Cells: In Vitro and In Vivo Studies , 2011, Journal of biomedicine & biotechnology.

[108]  S. Lalwani,et al.  Spinal cord injury. , 2011, Journal of neurosurgery. Spine.

[109]  M. Stewart,et al.  Mesenchymal stem cells: characteristics, sources, and mechanisms of action. , 2011, The Veterinary clinics of North America. Equine practice.

[110]  S. Kang,et al.  Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.

[111]  H. Feng,et al.  Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells , 2010, Critical care medicine.

[112]  Y. Joe,et al.  A Comparison of ROCK Inhibitors on Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Neuron-Like Cells , 2010 .

[113]  Haisheng Peng,et al.  In vitro differentiation of bone marrow stromal cells into neurons and glial cells and differential protein expression in a two-compartment bone marrow stromal cell/neuron co-culture system , 2010, Journal of Clinical Neuroscience.

[114]  L F Geffner,et al.  Administration of Autologous Bone Marrow Stem Cells into Spinal Cord Injury Patients via Multiple Routes is Safe and Improves their Quality of Life: Comprehensive Case Studies , 2008, Cell transplantation.

[115]  Michael G Fehlings,et al.  Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. , 2008, Neurosurgical focus.

[116]  U. Bogdahn,et al.  The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. , 2006, Biomaterials.

[117]  A. Asawachaicharn,et al.  Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis , 2006, Experimental Neurology.

[118]  J. Zimmer,et al.  Neural transdifferentiation of mesenchymal stem cells – a critical review , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[119]  G. Moonen,et al.  Plasticity of Cultured Mesenchymal Stem Cells: Switch from Nestin‐Positive to Excitable Neuron‐Like Phenotype , 2005, Stem cells.

[120]  J. Shumsky,et al.  Treatments for , 2004 .

[121]  Christian Clausen,et al.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. , 2003, Bone.

[122]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[123]  R. Class,et al.  Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.

[124]  H. Winn,et al.  Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. , 1998, Journal of neurosurgery.

[125]  E. Seifried,et al.  Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. , 2017, Cytotherapy.

[126]  L. Slovinská,et al.  Axonal outgrowth stimulation after alginate/mesenchymal stem cell therapy in injured rat spinal cord. , 2017, Acta neurobiologiae experimentalis.

[127]  M. Pittenger,et al.  Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects. , 2016, Transfusion medicine reviews.

[128]  R. Henschler,et al.  Fate of intravenously injected mesenchymal stem cells and significance for clinical application. , 2013, Advances in biochemical engineering/biotechnology.

[129]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[130]  Qin-jun Zhao,et al.  Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. , 2006, Haematologica.

[131]  J. Neuwirth,et al.  Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. , 2006, Cell transplantation.